Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury
A method for protection of tissues subject to ischemic and/or reperfusion damage is provided. The method includes administering to the tissue a composition comprising nanodevices. The nanodevices can take the form of, for example, polymeric nanoparticles or lipidic nanoparticles. The nanodevices also find use in methods for reducing ischemic injury in tissue at risk of such injury, such as heart and brain tissue.
1. A method for reducing ischemic reperfusion injury to a tissue, comprising administering intravascularly to the tissue a composition comprising a nanodevice having a diameter of about 10-1000 nm, wherein said nanodevice is selected from the group consisting of nanoparticles, nanorods, nanospheres, and nanobubbles in the absence of a therapeutic agent.
2. The method of claim 1 , wherein said administering comprises administering during organ or tissue harvest.
3. The method of claim 1 , wherein said administering comprises administering during organ or tissue transplantation.
4. The method of claim 1 , wherein said administering comprises administering during surgery.
5. The method of claim 1 , wherein said administering comprises administering polymeric nanodevices.
6. A method for conferring protection to a tissue at risk of an ischemic reperfusion injury, comprising administering intravascularly to the tissue a composition comprised of polymer or lipidic nanodevices in the absence of a therapeutic agent, each nanodevice having a diameter of between about 10-1000 nm, wherein said nanodevice is selected from the group consisting of nanoparticles, nanorods, nanospheres, and nanobubbles.
7. The method of claim 6 , wherein said administering comprising administering prior to a scheduled ischemic event.
8. The method of claim 7 , wherein said scheduled ischemic event is surgery.
9. The method of claim 8 , wherein said administering is at least about 12 hours prior to surgery.
10. The method of claim 6 , wherein said administering comprising administering chronically prior to an unscheduled ischemic reperfusion event.
11. The method of claim 10 , wherein said administering is at least about monthly.
12. The method of claim 1 , wherein said nanodevice comprises a plurality of nanoparticles, nanorods, nanospheres, or nanobubbles, each having a diameter of between about 10-1000 nm.